IRMD logo

IRadimed (IRMD) Cash From Operations

Annual CFO

$13.46 M
+$3.42 M+34.08%

December 31, 2023

Summary

Performance

1-Year Change

+34.08%

3-Year Change

+131.46%

5-Year Change

+82.55%

15-Year Change

+294.19%

IRMD Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.63%
IRMD annual cash flow from operations is higher than 81.63% of companies in Healthcare sector

High & Low

All-time High

$13.46 M
IRMD annual cash flow from operations is currently at an all-time high

3-Year Low

$10.04 M
IRMD annual cash flow from operations is currently +34.08% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
IRMD previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 13, 2025
IRMD next annual earnings announcement is scheduled for Feb 13, 2025

OtherIRMDcash flowmetrics:

Annual CFI

-$8.01 M
IRMD annual cash flow from investing activities is -$8.01 million

Annual CFF

-$13.66 M
IRMD annual cash flow from financing activities is -$13.66 million

Annual FCF

$5.46 M
IRMD annual free cash flow is $5.46 million

Annual CAPEX

$8.01 M
IRMD annual capital expenditures is $8.01 million

Quarterly CFO

$9.12 M
+$2.48 M+37.32%

September 30, 2024

Summary

Performance

3-Month Change

+37.32%

1-Year Change

+37.32%

3-Year Change

+37.32%

5-Year Change

+37.32%

IRMD Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.7%
IRMD quarterly cash flow from operations is higher than 80.7% of companies in Healthcare sector

High & Low

All-time High

$9.12 M
IRMD quarterly cash flow from operations is currently at an all-time high

3-Year Low

$1.39 M
IRMD quarterly cash flow from operations is currently +554.53% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IRMD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
IRMD next earnings announcement is scheduled for Feb 13, 2025

OtherIRMDcash flowmetrics:

Quarterly CFI

-$4.01 M
IRMD quarterly cash flow from investing activities is -$4.01 million

Quarterly CFF

-$1.92 M
IRMD quarterly cash flow from financing activities is -$1.92 million

Quarterly FCF

$5.10 M
IRMD quarterly free cash flow is $5.10 million

Quarterly CAPEX

$4.01 M
IRMD quarterly capital expenditures is $4.01 million

TTM CFO

$23.55 M
+$7.72 M+48.80%

September 30, 2024

Summary

Performance

3-Month Change

+48.8%

1-Year Change

+48.8%

3-Year Change

+48.8%

5-Year Change

+48.8%

IRMD TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.83%
IRMD TTM cash flow from operations is higher than 81.83% of companies in Healthcare sector

High & Low

All-time High

$23.55 M
IRMD TTM cash flow from operations is currently at an all-time high

3-Year Low

$9.81 M
IRMD TTM cash flow from operations is currently +140.07% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IRMD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
IRMD next earnings announcement is scheduled for Feb 13, 2025

OtherIRMDcash flowmetrics:

TTM CFI

-$6.39 M
IRMD TTM cash flow from investing activities is -$6.39 million

TTM CFF

-$12.18 M
IRMD TTM cash flow from financing activities is -$12.18 million

TTM FCF

$17.16 M
IRMD TTM free cash flow is $17.16 million

TTM CAPEX

$6.39 M
IRMD TTM capital expenditures is $6.39 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IRMD Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.1%+37.3%+48.8%
3 y3 years+131.5%+37.3%+48.8%
5 y5 years+82.5%+37.3%+48.8%

IRMD Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+34.1%at high+554.5%at high+140.1%
5 y5-yearat high+131.5%at high+1053.0%at high+323.3%
alltimeall timeat high+813.3%at high+1111.3%at high>+9999.0%

IRadimed Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$9.12 M(+37.3%)
$23.55 M(+48.8%)
Jun 2024
-
$6.64 M(+71.0%)
$15.83 M(+24.6%)
Mar 2024
-
$3.88 M(-0.7%)
$12.70 M(-5.7%)
Dec 2023
$13.46 M(+34.1%)
$3.91 M(+180.9%)
$13.47 M(+6.9%)
Sep 2023
-
$1.39 M(-60.4%)
$12.59 M(-16.8%)
Jun 2023
-
$3.51 M(-24.4%)
$15.14 M(+14.1%)
Mar 2023
-
$4.65 M(+52.9%)
$13.26 M(+32.1%)
Dec 2022
$10.04 M(-10.8%)
$3.04 M(-22.8%)
$10.04 M(-3.2%)
Sep 2022
-
$3.94 M(+140.3%)
$10.37 M(+5.7%)
Jun 2022
-
$1.64 M(+14.9%)
$9.81 M(-16.5%)
Mar 2022
-
$1.43 M(-57.6%)
$11.74 M(+4.3%)
Dec 2021
$11.26 M(+93.5%)
$3.37 M(-0.4%)
$11.26 M(+8.4%)
Sep 2021
-
$3.38 M(-5.4%)
$10.39 M(+24.5%)
Jun 2021
-
$3.57 M(+278.6%)
$8.34 M(+50.0%)
Mar 2021
-
$943.10 K(-62.2%)
$5.56 M(-4.4%)
Dec 2020
$5.82 M(-43.1%)
$2.50 M(+87.1%)
$5.82 M(-20.0%)
Sep 2020
-
$1.33 M(+68.8%)
$7.27 M(-19.9%)
Jun 2020
-
$790.60 K(-33.9%)
$9.07 M(-15.7%)
Mar 2020
-
$1.20 M(-69.7%)
$10.76 M(+5.2%)
Dec 2019
$10.23 M(+38.7%)
$3.95 M(+25.8%)
$10.23 M(+4.1%)
Sep 2019
-
$3.14 M(+26.5%)
$9.83 M(+32.5%)
Jun 2019
-
$2.48 M(+272.9%)
$7.42 M(+14.8%)
Mar 2019
-
$665.20 K(-81.2%)
$6.46 M(-12.5%)
Dec 2018
$7.38 M
$3.54 M(+386.7%)
$7.38 M(+40.9%)
DateAnnualQuarterlyTTM
Sep 2018
-
$727.90 K(-52.2%)
$5.23 M(-18.4%)
Jun 2018
-
$1.52 M(-3.9%)
$6.41 M(+23.7%)
Mar 2018
-
$1.58 M(+13.0%)
$5.18 M(+51.8%)
Dec 2017
$3.42 M(-63.7%)
$1.40 M(-26.6%)
$3.42 M(-19.4%)
Sep 2017
-
$1.91 M(+554.5%)
$4.24 M(-26.3%)
Jun 2017
-
$291.50 K(-257.9%)
$5.75 M(-15.3%)
Mar 2017
-
-$184.60 K(-108.3%)
$6.79 M(-27.8%)
Dec 2016
$9.41 M(+23.0%)
$2.22 M(-35.0%)
$9.41 M(-3.5%)
Sep 2016
-
$3.42 M(+157.2%)
$9.75 M(+12.4%)
Jun 2016
-
$1.33 M(-45.3%)
$8.67 M(-3.9%)
Mar 2016
-
$2.43 M(-5.3%)
$9.03 M(+18.0%)
Dec 2015
$7.65 M(+195.8%)
$2.57 M(+9.5%)
$7.65 M(+82.9%)
Sep 2015
-
$2.34 M(+39.2%)
$4.18 M(+35.9%)
Jun 2015
-
$1.68 M(+59.4%)
$3.08 M(-3.2%)
Mar 2015
-
$1.06 M(-217.2%)
$3.18 M(+23.0%)
Dec 2014
$2.59 M(+75.4%)
-$901.40 K(-172.7%)
$2.59 M(-39.2%)
Sep 2014
-
$1.24 M(-30.6%)
$4.25 M(+33.0%)
Jun 2014
-
$1.79 M(+286.4%)
$3.20 M(+61.0%)
Mar 2014
-
$462.10 K(-39.8%)
$1.99 M(+34.8%)
Dec 2013
$1.47 M(-2.3%)
$767.60 K(+315.1%)
$1.47 M(+108.6%)
Sep 2013
-
$184.90 K(-67.7%)
$706.70 K(+35.4%)
Jun 2013
-
$572.90 K(-1221.1%)
$521.80 K(-1121.1%)
Mar 2013
-
-$51.10 K
-$51.10 K
Dec 2012
$1.51 M
-
-

FAQ

  • What is IRadimed annual cash flow from operations?
  • What is the all time high annual CFO for IRadimed?
  • What is IRadimed annual CFO year-on-year change?
  • What is IRadimed quarterly cash flow from operations?
  • What is the all time high quarterly CFO for IRadimed?
  • What is IRadimed quarterly CFO year-on-year change?
  • What is IRadimed TTM cash flow from operations?
  • What is the all time high TTM CFO for IRadimed?
  • What is IRadimed TTM CFO year-on-year change?

What is IRadimed annual cash flow from operations?

The current annual CFO of IRMD is $13.46 M

What is the all time high annual CFO for IRadimed?

IRadimed all-time high annual cash flow from operations is $13.46 M

What is IRadimed annual CFO year-on-year change?

Over the past year, IRMD annual cash flow from operations has changed by +$3.42 M (+34.08%)

What is IRadimed quarterly cash flow from operations?

The current quarterly CFO of IRMD is $9.12 M

What is the all time high quarterly CFO for IRadimed?

IRadimed all-time high quarterly cash flow from operations is $9.12 M

What is IRadimed quarterly CFO year-on-year change?

Over the past year, IRMD quarterly cash flow from operations has changed by +$2.48 M (+37.32%)

What is IRadimed TTM cash flow from operations?

The current TTM CFO of IRMD is $23.55 M

What is the all time high TTM CFO for IRadimed?

IRadimed all-time high TTM cash flow from operations is $23.55 M

What is IRadimed TTM CFO year-on-year change?

Over the past year, IRMD TTM cash flow from operations has changed by +$7.72 M (+48.80%)